"
Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. This market exclusively covers product sales through pharmacies.
Additional information:
The Sleep Aids market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Sleep Aids (Pharmacies) market in Africa is experiencing significant growth and development.
Customer preferences: Customers in Africa are increasingly seeking sleep aids to address their sleep-related issues. The fast-paced and stressful lifestyles in many African countries have led to a rise in sleep disorders and insomnia. As a result, there is a growing demand for sleep aids in pharmacies across the continent. Customers are looking for effective and safe solutions to improve their sleep quality and overall well-being.
Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market in Africa is the increasing availability and variety of sleep aids. Pharmacies are expanding their product offerings to meet the growing demand. Customers now have access to a wide range of over-the-counter sleep aids, including herbal remedies, melatonin supplements, and prescription medications. This trend is driven by the need for convenience and accessibility, as customers prefer to purchase sleep aids directly from their local pharmacies. Another trend in the market is the growing popularity of natural and herbal sleep aids. African customers have a strong preference for natural remedies and are increasingly turning to herbal sleep aids, such as valerian root and chamomile. This trend is influenced by the cultural beliefs and traditional medicine practices in many African countries, where natural remedies are highly valued. Pharmacies are responding to this trend by stocking a variety of natural sleep aids to cater to customer preferences.
Local special circumstances: The Sleep Aids (Pharmacies) market in Africa is also influenced by local special circumstances. In many African countries, access to healthcare services is limited, and visiting a doctor for sleep-related issues may not always be feasible. As a result, customers rely heavily on pharmacies for their healthcare needs, including sleep aids. Pharmacies play a crucial role in providing accessible and affordable solutions to address sleep disorders.
Underlying macroeconomic factors: The development of the Sleep Aids (Pharmacies) market in Africa is supported by underlying macroeconomic factors. Economic growth and rising disposable incomes in many African countries have led to an increase in healthcare spending. As people become more aware of the importance of sleep and its impact on overall health, they are willing to invest in sleep aids to improve their well-being. The growing middle class in Africa is a key driver of this trend, as they have the financial means to purchase sleep aids from pharmacies. In conclusion, the Sleep Aids (Pharmacies) market in Africa is experiencing growth and development due to customer preferences for effective sleep solutions, the availability of a wide range of sleep aids in pharmacies, the popularity of natural remedies, the reliance on pharmacies for healthcare needs, and the underlying macroeconomic factors such as economic growth and rising disposable incomes.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.